INSIGHTS  /  ARTICLES

Financial Services Firm Resources, GLG Updates and Expert Network Content, Healthcare and Life Sciences

Shaping the Future of Healthcare with AI

The healthcare industry represents one of the most promising applications for AI and machine learning. These technologies could transform how we deliver patient care, discover new therapeutics, control healthcare costs, and eliminate time-consuming administrative tasks. 
 
GLG brought together leading subject-matter experts to discuss how AI and machine learning will drive the future of patient care and the broader healthcare industry.

Featured experts: 

  • Prashanth Sarpamale, Former Chief Data Analytics Officer at Oak Street Health 
  • Paul Martino, Founder of VillageMD 
  • Douglas Kondziolka, MD, Vice-Chair of Neurosurgery at NYU Langone Medical Center 

 

Key takeaways: 

Integrating AI into Existing Workflows
Prashanth stressed the importance of ensuring that AI technologies are seamlessly integrated into existing healthcare systems. “AI should fit naturally into current workflows to truly add value,” he said.  

Reproducibility in Medical AI
Douglas shared, “Reproducibility is key to ensuring AI works at scale in clinical settings,” and emphasized that machine learning models in healthcare must deliver consistent, reliable outcomes to build trust among patients and providers.  

Understanding the Core Problem
For Paul, the success of AI in healthcare hinges on identifying the specific problems AI can solve and understanding who benefits from these solutions. “AI’s true value comes from solving real, tangible challenges,” he explained. 

Looking Ahead: The Future of AI in Healthcare

The experts agreed that while AI adoption in healthcare is still in its early stages, the potential for long-term impact is significant. Prashanth suggested that investors should pay close attention to shifts in the healthcare ecosystem to identify companies that are well-positioned for future success.

Balancing Innovation and Regulation
The discussion turned to the balance between innovation and regulation in the healthcare sector. “We need common sense regulation that allows innovation without compromising security,” Prashanth stated. The experts were unified in their view that thoughtful regulation is essential to ensuring patient safety while allowing space for innovation. 

AI’s Gradual Impact
The panel also explored the incremental progress of AI in healthcare, with both Prashanth and Douglas likening it to a “battle of inches.” Many improvements are happening behind the scenes and may be invisible to patients, but they are essential for improving operational efficiency. Paul suggested investors take a cautious approach, remembering that the healthcare system is already functioning well for many people. “Healthcare doesn’t need to change overnight,” he said. “Investors should remember that AI is an evolving tool, not a silver bullet.” 

 

This event was part of Perspectives, GLG’s event series giving clients and experts insight into today’s most important topics from every key angle.  

Contact Us

Enter your contact information below and a member of our team will reach out to you shortly.

Speaker Biographies

Hilary Malone PhD, has over 25 years of experience in global drug development, regulatory &government affairs, manufacturing and commercialization within the biopharma industry. Hilary hassignificant board level and executive committee experience including large scale organizationalrestructuring/transformation/integration, major M&A, biotech start-up, capital raising, investorrelations and pre-IPO.​

Hilary is currently CEO of Stylus Medicine, a private genetic medicine biotech company. Previously sheserved as CEO of a Series-A neuroscience company. Prior to these roles, Hilary served as COO & EVP atValo Health Inc., Chief Regulatory Officer & SVP at Sanofi Inc., and Chief Regulatory Officer & SVP atPfizer and Wyeth. Previous experience also includes senior regulatory and drug development roles atReata Pharmaceuticals Inc., AstraZeneca plc and GlaxoSmithKline plc.​

Hilary also serves on the Board of Directors of Hansa Biopharma and Adthera Bio. Hilary holds a PhD inMolecular Neuropharmacology and a BSc in Physiology.

Dr. Thomas Lönngren is Director at his own company PharmaExec Consulting AB. He is the Chairman of the Board of directors at Egetis Therapeutics AB, Sweden. Dr Lönngren also serves as board member at Compass Pathways PLC, London UK and NDA Group, Sweden. He acts as advisor to the following companies and organizations: NDA group, Sweden, Sweden, Artis Venture, San Francisco, US, Fujimoto Japan, Skin2Neuron Pty Ltd, Sydney, Australia, US, Special advisor to the Centre for Innovation in Regulatory Science (CIRS), London UK. From 2001 until2011, Mr.Lönngren served as the Executive Director of the European Medical Agency. He was previously Deputy General Director of the Swedish Medical Product Agency until 2000. He has a degree in pharmacy and MSc in Social and Regulatory Pharmacy from Uppsala University. He is also an Honorary Member of the Royal Pharmaceutical Society of Great Britain, Honorary Fellow of the Royal College of Physicians in Great Britain, Honorary Doctorate from the University of Uppsala, Honorary Doctorate from University of Bath, UK.

Speaker Biographies

Marie-Anne Aymerich

Marie-Anne has built a portfolio of senior advisory and non-executive roles, following a successful international career in the FMCG and Luxury sectors. She is a non-executive director of Haleon, a FTSE100 company listed in 2022 after the demerger from GSK. She is also chairwoman of Haleon Environment and Societal Sustainability committee. She is the executive director of the Pierre Fabre Group where she also sits on the Strategic Committee, and she is a Board Member of The Academy of St. Martin-in-the-Fields, one of the world’s most prestigious chamber orchestras. She is also an angel investor and focuses her time and investments on start-ups with the strongest purpose and impact.

Marie-Anne is also a regular lecturer at HEC Paris on purposeful leadership, and she has created a serious game called “Planet Purpose” to upskill people on sustainability and purpose. Throughout her 35year executive career she delivered a strong track-record of business performance and growth in brands and portfolio in both developed and emerging economies.

As a senior leader with Unilever, she led a number of different personal care categories across France, Spain and the USA – including managing the Dove brand worldwide and culminating in leading Unilever’s global Oral Care division. She also worked for LVMH as Brand General Manager of Dior Perfumes and Cosmetics worldwide. Marie-Anne was also Vice-President of Imagine for Margo – Children with Cancer for ten years, a charity she helped found in 2011 with the goal of eradicating children’s cancer. The charity is the #1 charity focused on child cancer in France and has fundraised more than €14m since its creation. Marie-Anne is a graduate from HEC Paris. She is married and has two children aged 29 and 26.

Patrick Jephson

Patrick Jephson is a consultant, journalist, broadcaster and New York Times bestselling author, based in Washington D.C. He is a published authority on corporate and personal branding and crisis communications, addressing conferences worldwide as well as events at the U.S. State Department, the American University and the Annenberg School for Communication and Journalism.

With more than twenty-five years’ experience in the government, luxury and family office sectors, Patrick’s portfolio has included globally admired brands as well as national agencies and NGOs. He has also worked on reputation and legacy briefs with European, Middle Eastern and Asian families, including royalty. He now writes, presents, and advises on factual and drama TV programs, appearing on every major American and many international networks. He was recently an expert consultant to the award-winning Netflix series The Crown and provided live commentary on the Coronation of King Charles.

Patrick owes much of his practical communications and protocol experience to Princess Diana, who chose him to be her equerry and only private secretary/chief of staff. He served the Princess for eight years, responsible for all aspects of her public life, global humanitarian initiatives, and private organization. Having worked for an internationally high-profile woman (and as the father of two professionally successful daughters) he feels a special affinity for cross-cultural, gender and perception issues.

Patrick was born and raised in Ireland and holds a master’s degree in political science from Cambridge University. As an officer in the British Royal Navy, he served all over the world before being selected for royal duty. He is a citizen of the U.K., U.S.A., Ireland, and Canada.